Trial Profile
A Single-center, Double-blind, Randomized, Placebo-controlled, Two Period / Two Treatment Cross-over Study to Assess the Effect of Florastor (Saccharomyces Boulardii Lyo) on Gastrointestinal Tolerability, Safety, and Pharmacokinetics of Zavesca (Miglustat) in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Mar 2015
Price :
$35
*
At a glance
- Drugs Miglustat (Primary) ; Saccharomyces boulardii
- Indications Cystic fibrosis; Gaucher's disease type I; Hepatitis C; Niemann-Pick diseases
- Focus Adverse reactions
- Sponsors Actelion Pharmaceuticals
- 09 Mar 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 04 Apr 2014 New trial record